Net loss of Samrat Pharmachem reported to Rs 0.59 crore in the quarter ended September 2025 as against net profit of Rs 2.66 crore during the previous quarter ended September 2024. Sales rose 12.40% to Rs 78.87 crore in the quarter ended September 2025 as against Rs 70.17 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales78.8770.17 12 OPM %-0.464.80 - PBDT-0.573.69 PL PBT-0.753.52 PL NP-0.592.66 PL Powered by Capital Market - Live News

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News

Net loss of Samrat Pharmachem reported to Rs 0.23 crore in the quarter ended June 2025 as against net profit of Rs 2.07 crore during the previous quarter ended June 2024. Sales declined 6.40% to Rs 75.65 crore in the quarter ended June 2025 as against Rs 80.82 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales75.6580.82 -6 OPM %0.173.19 - PBDT0.382.98 -87 PBT0.212.82 -93 NP-0.232.07 PL Powered by Capital Market - Live News

Samrat Pharmachem will hold a meeting of the Board of Directors of the Company on 13 August 2025.Powered by Capital Market - Live News

Samrat Pharmachem announced that the 33th Annual General Meeting(AGM) of the company will be held on 25 September 2025.Powered by Capital Market - Live News